Form D · Hedge Fund

Janus Henderson Biotech Innovation Fund II Access LLC

New York, NY · CIK 0002085092

Offering snapshot reported Oct 13, 2026 · SEC filing

Reported sold
$155M
Indefinite offering
Investors reported
610
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 1, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$77.5M$155MSep 16, 2025: $3,225,000.00Sep 16, 2025Oct 13, 2026: $155,006,441.00Oct 13, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,225,000 → $155,006,441
  • Reported investors8 → 610
  • Minimum accepted$100,000 → $0

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2026Amendment$155,006,441$151,781,441vs Sep 16, 2025610SEC filing
Sep 16, 2025Initial$3,225,000No comparison8SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0
Form D file number
021-557611
Estimated maximum aggregate sales commission to be paid to the selling agents. The sales commission to be deducted from the subscription amount is up to 2%.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Merrill Lynch, Pierce, Fenner & Smith Incorporated7691

Source: Form D, filed Oct 13, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Asterion Fund Services, L.L.C. Promoter
N/A Asterion Fund Services, L.L.C. Promoter
Andrea Capeci Executive
Coleen Gasiewski Executive
Scott Huff Executive
I Capital Alternative Investments Llc Executive
N/A I Capital Alternative Investments Llc ("I Capital") Executive
Maples Fiduciary Services (Delaware) Inc. Executive
N/A Maples Fiduciary Services (Delaware) Inc. ("Mfsd Inc.") Executive
Max Schwartz Executive
Edward L. Truitt, Jr. Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Compliance Department 60 East 42 Nd Street, 24 Th Floor
New York, NY, 10165